/Investor DB

aMoon — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Omada Healthomadahealth.comin𝕏NASDAQ: OMDAFeb 2022 · $190M

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Founder)inSean Duffy(Founder)inWei-Li Shao(President)inSteve Cook(Chief Financial Officer)inAndrew DiMichele(Founder)

Co-investorsAndreessen HorowitzBlackbird VenturesCanvas VenturesCivilization Ventures Management, LlcDesigner FundEnsemble Labs+19 more

Satellite Biosatellite.bioSeries A · Mar 2022 · $82M

Satellite Bio develops an off-the-shelf cell therapy that delivers functional liver cells (hepatocytes) into the body, where they engraft to restore liver function.

BiotechHealthtechCambridge, US

Christopher Chen(Director, Promoter)inThomas Lowery(Executive Officer)

BoardEllie McGuire(Director)Ling Wong(Director)Sujata Bhatia(Director)William Young(Director)

Board seatYair Schindel· per SEC Form D

Co-investorsAlumni VenturesCatalio Capital Management, LPLightspeed Venture PartnersHighbury HoldingsPolaris PartnersS32

Lyfegenlyfegen.comin𝕏Sep 2022 · $8M

Lyfegen provides a software platform for managing value-based and outcome-based healthcare contracts and drug pricing agreements between pharmaceutical companies, health insurers (payers), and providers.

Digital HealthHealthtechSaaSBasel, CH

Girisha Fernando(CEO & Founder)inMichel Mohler(CFO & Founder)Nico Julian Mros(CXO & Founder)in

Co-investorsAPEX VenturesTX Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.